Detalles de la búsqueda
1.
JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route.
J Virol
; 89(2): 1340-7, 2015 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25392214
2.
Viral miRNAs in plasma and urine divulge JC polyomavirus infection.
Virol J
; 11: 158, 2014 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25178457
3.
Circulating human microRNAs are not linked to JC polyomavirus serology or urinary viral load in healthy subjects.
Virol J
; 11: 41, 2014 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-24588811
4.
Antibodies reacting with JCPyV_VP2 _167-15mer as a novel serological marker for JC polyomavirus infection.
Virol J
; 11: 174, 2014 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25273879
5.
The miRNA world of polyomaviruses.
Virol J
; 10: 268, 2013 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23984639
6.
An antibody response to human polyomavirus 15-mer peptides is highly abundant in healthy human subjects.
Virol J
; 10: 192, 2013 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23758776
7.
Metabolic and body mass parameters after treatment with JNJ-37822681, a novel fast-dissociating D2 receptor antagonist, vs olanzapine in patients with schizophrenia.
Ann Clin Psychiatry
; 25(3): 173-83, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23926573
8.
Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based ß-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial.
J Med Chem
; 64(4): 1873-1888, 2021 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33588527
9.
Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study.
Alzheimers Res Ther
; 12(1): 58, 2020 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410694
10.
Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease.
Neurobiol Aging
; 79: 131-141, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31055223
11.
Evaluating Potential QT Effects of JNJ-54861911, a BACE Inhibitor in Single- and Multiple-Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration-QTc Analysis.
J Clin Pharmacol
; 58(7): 952-964, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29505101
12.
Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study.
Alzheimers Res Ther
; 10(1): 85, 2018 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30134967
13.
BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.
J Alzheimers Dis
; 56(4): 1437-1449, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28157093
14.
Profiling the dynamics of CSF and plasma Aß reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor.
Alzheimers Dement (N Y)
; 2(3): 202-212, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29067308
15.
Characterization of Rabbit Antibodies Against the Immunogenic JC Polyomavirus Peptide JCPyV_VP2_167-15mer.
Viral Immunol
; 28(7): 405-9, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26075335
16.
Quasispecies analysis of JC virus DNA present in urine of healthy subjects.
PLoS One
; 8(8): e70950, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23967139
17.
Does early improvement predict response to the fast-dissociating D2 receptor antagonist JNJ-37822681 in patients with acute schizophrenia?
Eur Neuropsychopharmacol
; 23(9): 1043-50, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22995972
Resultados
1 -
17
de 17
1
Próxima >
>>